News
First risk score to predict bleeding risk after TAVR
June 11, 2021
PREDICT-TAVR was developed and validated in two national registries in Europe and outperformed existing risk scores developed outside TAVR.
News
Medication in heart failure: Pro tips on therapy with the ‘four pillars of survival’
June 4, 2021
Consider multiple factors when titrating various medications.
![1]()
News
In-hospital resuscitation: Focus on effective chest pumps, prompt shocks
June 3, 2021
Consider mechanical piston compressions and even “reverse CPR” when appropriate.
![1]()
News
Subclinical myocarditis found in some athletes post COVID
June 2, 2021
A study that evaluated college athletes recently infected with COVID-19 with comprehensive cardiac testing, including MRI, found a small percentage had myocarditis despite being asymptomatic.
![1]()
News
Single subcutaneous shot offers fast, potent platelet inhibition in STEMI
June 1, 2021
The effect was seen within 15 minutes of receiving RUC-4, an investigational glycoprotein IIb/IIIa inhibitor, with no thrombocytopenia, in a phase 2a study.
![1]()
News
Significant reduction of alcohol intake reduced AFib burden and recurrence
June 1, 2021
In patients with symptomatic paroxysmal or persistent AFib who report alcohol consumption of 10 or more standard drinks per week, how does reducing alcohol intake affect AFib outcomes?
![1]()
News
New AHA/ASA guideline on secondary stroke prevention
May 27, 2021
Identifying the cause of a first stroke or transient ischemic attack is key to developing strategies to prevent repeat events, the AHA/ASA says in an updated clinical practice guideline.
News
AHA reassures myocarditis rare after COVID vaccination, benefits overwhelm risks
May 24, 2021
As CDC investigates rare, mostly mild cases of myocarditis in adolescents and young adults given the Pfizer or Moderna vaccine, AHA emphasizes their effectiveness and strong safety record.
![1]()
News
GALACTIC-HF: Novel drug most effective in sickest HFrEF patients
May 24, 2021
In GALACTIC-HF trial, the greatest relative benefit of omecamtiv mecarbil was in the sickest HFrEF patients.
![1]()
News
Sotagliflozin’s HFpEF benefit confirmed by new analyses
May 24, 2021
A meta-analysis of two pivotal trials for the SGLT1/2 inhibitor sotagliflozin prospectively documents a HFpEF benefit.
